全文获取类型
收费全文 | 16654篇 |
免费 | 1465篇 |
国内免费 | 913篇 |
专业分类
耳鼻咽喉 | 153篇 |
儿科学 | 199篇 |
妇产科学 | 330篇 |
基础医学 | 2055篇 |
口腔科学 | 343篇 |
临床医学 | 2221篇 |
内科学 | 2601篇 |
皮肤病学 | 241篇 |
神经病学 | 866篇 |
特种医学 | 463篇 |
外国民族医学 | 7篇 |
外科学 | 1801篇 |
综合类 | 2425篇 |
现状与发展 | 1篇 |
一般理论 | 11篇 |
预防医学 | 928篇 |
眼科学 | 421篇 |
药学 | 1727篇 |
8篇 | |
中国医学 | 695篇 |
肿瘤学 | 1536篇 |
出版年
2024年 | 52篇 |
2023年 | 241篇 |
2022年 | 532篇 |
2021年 | 729篇 |
2020年 | 545篇 |
2019年 | 539篇 |
2018年 | 589篇 |
2017年 | 481篇 |
2016年 | 444篇 |
2015年 | 721篇 |
2014年 | 901篇 |
2013年 | 910篇 |
2012年 | 1302篇 |
2011年 | 1423篇 |
2010年 | 894篇 |
2009年 | 706篇 |
2008年 | 883篇 |
2007年 | 907篇 |
2006年 | 858篇 |
2005年 | 827篇 |
2004年 | 581篇 |
2003年 | 553篇 |
2002年 | 400篇 |
2001年 | 372篇 |
2000年 | 375篇 |
1999年 | 435篇 |
1998年 | 264篇 |
1997年 | 258篇 |
1996年 | 177篇 |
1995年 | 164篇 |
1994年 | 132篇 |
1993年 | 96篇 |
1992年 | 111篇 |
1991年 | 85篇 |
1990年 | 75篇 |
1989年 | 59篇 |
1988年 | 87篇 |
1987年 | 74篇 |
1986年 | 45篇 |
1985年 | 43篇 |
1984年 | 22篇 |
1983年 | 20篇 |
1982年 | 14篇 |
1981年 | 11篇 |
1980年 | 7篇 |
1979年 | 28篇 |
1978年 | 9篇 |
1975年 | 8篇 |
1974年 | 8篇 |
1972年 | 7篇 |
排序方式: 共有10000条查询结果,搜索用时 20 毫秒
151.
目的 探讨合作医院人文关怀护理推进策略及效果.方法 选派护理专家至合作医院进行驻点指导,建立人文关怀护理组织架构,制定人文关怀护理标准和制度,强化护理管理和服务理念,实施人文关怀培训、试点病房人文关怀护理,督导推进人文关怀护理规范化,全面推进合作医院人文关怀护理.结果 合作医院建立首批人文关怀试点病房12个,实施后护士关怀能力显著高于实施前(P<0.01),患者对关怀护理满意度及护士工作满意度逐步提升.结论 人文关怀护理推进策略在合作医院的推进,促进了护士对患者的关怀、护理管理者对护士的关怀,可有效提高患者满意度、护士的关怀能力和工作满意度. 相似文献
152.
目的观察长链非编码RNA Linc00472(LncRNA Linc00472)靶向调控微小RNA-381(miR-381)对骨肉瘤细胞增殖、凋亡、迁移、侵袭的影响。方法收集2017年3月至2018年5月郑州大学第一附属医院收治的骨肉瘤患者29例为研究对象,实时荧光定量聚合酶链反应(RT-qPCR)检测骨肉瘤组织和瘤旁组织中Linc00472的表达。将骨肉瘤U2OS细胞分为pcDNA3.1组、pcDNA3.1-Linc00472组、pcDNA3.1-Linc00472+miR-NC组、pcDNA3.1-Linc00472+miR-381组。甲基噻唑基四唑(MTT)检测细胞增殖;流式细胞术检测细胞凋亡;Transwell实验检测细胞迁移及侵袭。双荧光素酶报告实验鉴定Linc00472与miR-381的靶向关系。两组间比较采用独立样本t检验,多组间比较采用单因素方差分析。结果Linc00472在骨肉瘤组织中的表达水平低于瘤旁组织(0.31±0.03比1.03±0.10,t=37.138,P<0.05),差异有统计学意义;与pcDNA3.1组比较,pcDNA3.1-Linc00472组细胞存活率[(100.29±10.12)%比(53.29±5.44)%]低于pcDNA3.1组(t=12.272,P<0.05),差异有统计学意义,迁移细胞数[(266.00±23.61)个比(124.00±12.01)个]与侵袭细胞数[(131.00±13.06)个比(62.00±6.24)个]少于pcDNA3.1组(t=16.082,P<0.05;t=14.301,P<0.05),差异有统计学意义,而细胞凋亡率[(8.58±0.91)%比(26.61±2.64)%]高于pcDNA3.1组(t=19.370,P<0.05),差异有统计学意义;miR-381过表达可抑制野生型载体WT-Linc00472细胞的荧光素酶活性(t=19.827,P<0.05),差异有统计学意义;与pcDNA3.1-Linc00472+miR-NC组比较,pcDNA3.1-Linc00472+miR-381组可增强细胞增殖[(53.17±5.33)%比(85.26±8.62)%]、迁移[(122.00±12.31)个比(223.00±22.18)个]及侵袭[(64.00±6.36)个比(104.00±10.20)个]能力高于pcDNA3.1-Linc00472+miR-NC组(t=9.499,P<0.05;t=11.945,P<0.05;t=9.983,P<0.05),细胞凋亡率[(26.11±2.62)%比(13.11±1.34)%]低于pcDNA3.1-Linc00472+miR-NC组(t=13.253,P<0.05),差异有统计学意义。结论LncRNA Linc00472通过靶向调控miR-381可抑制骨肉瘤细胞增殖、迁移及侵袭并诱导细胞凋亡。 相似文献
153.
Tanaz Vaghaiwalla Brian Ruhle Kelvin Memeh Peter Angelos Edwin Kaplan Chih-Yi Liao Blase Polite Xavier Keutgen 《Surgery》2021,169(1):162-167
BackgroundPeptide receptor radionuclide therapy is a targeted therapy used to treat unresectable somatostatin receptor-positive neuroendocrine tumors. The objective of this study was to evaluate response rates among neuroendocrine tumors of different primaries and identify factors relevant to future treatment strategies.MethodsWe retrospectively reviewed patients who received peptide receptor radionuclide therapy for neuroendocrine tumors from 2018 to 2019 at our institution. Patients were assessed with computed tomography/magnetic resonance imaging and 68Ga-DOTATATE-positron emission tomography before and after 2 or 4 cycles of peptide receptor radionuclide therapy. Tumor response was evaluated by RECIST 1.1. Statistics included multinomial logistic regression models and Fisher exact test.ResultsTwenty-seven patients underwent 92 cycles of peptide receptor radionuclide therapy: pancreas (n = 11), small bowel (n = 7), and other (n = 9) neuroendocrine tumors. Overall, 30% (8 of 27) had partial response, 59% (16 of 27) stable disease, and 11% (3 of 27) progressed. Pancreatic neuroendocrine tumors responded differently from small bowel neuroendocrine tumors regardless of cycle number (P = .01). The majority of pancreatic neuroendocrine tumors (6 of 11) had partial response to peptide receptor radionuclide therapy, while all small bowel neuroendocrine tumors had stable disease. Pancreatic neuroendocrine tumors stable after 2 cycles were more likely to respond to additional cycles versus other neuroendocrine tumors (probability: 60% vs 11%).ConclusionPatients with unresectable advanced or metastatic pancreatic neuroendocrine tumors may benefit from a full course of peptide receptor radionuclide therapy, whereas other neuroendocrine tumors appear less likely to respond. Large prospective studies are needed to confirm these findings. 相似文献
154.
155.
目的 分析2010-2019年凉山彝族自治州布拖县抗病毒治疗HIV/AIDS的死亡影响因素,为今后制定可持续的抗病毒治疗策略提供参考依据。方法 采用病例对照研究方法,收集2010-2019年布拖县接受抗病毒治疗HIV/AIDS与死亡者基本和随访信息,按病例数2倍抽样组成对照组,采用logistic回归模型分析其死亡的影响因素。结果 研究对象为抗病毒治疗的HIV/AIDS 3 355例,死亡组1 179例,对照组共2 176例。其中,30~49岁占81.34%,男性占69.09%,彝族占99.55%,已婚或同居占91.12%,初中及以下文化程度占95.77%,农民占88.41%。多因素logistic回归分析结果显示,研究对象的死亡风险因素中,年龄≥50岁是18~29岁的5.08倍(95%CI:3.05~8.48)、女性是男性的0.70倍(95%CI:0.52~0.94)、注射吸毒传播途径是异性性传播途径的1.43倍(95%CI:1.06~1.91)、治疗前CD4+T淋巴细胞计数(CD4)≥350个/μl是CD4<200个/μl的0.38倍(95%CI:0.30~0.48)、最近1次使用含洛匹那韦/利托那韦(LPV/r)抗病毒治疗方案是司他夫定(d4T)+拉米夫定(3TC)+奈韦拉平(NVP)/依非韦伦(EFV)方案的0.04倍(95%CI:0.01~0.18)、耐药是不耐药的3.40倍(95%CI:2.13~5.42),无病毒载量结果且未做耐药检测是不耐药的12.98倍(95%CI:10.28~16.40)。结论 年龄、性别、传播途径、治疗前CD4、最近1次抗病毒治疗方案、抗病毒治疗后耐药检测情况是布拖县接受抗病毒治疗HIV/AIDS的死亡影响因素。应扩大病毒载量和耐药检测覆盖面,科学更换抗病毒治疗方案,开展依从性教育和医务人员培训,降低抗病毒治疗HIV/AIDS死亡率。 相似文献
156.
157.
本文应用免疫细胞化学及NSE-ELISA方法观察了一氧化氮对体外培养脊髓和背根神经节神经元的存活及对活性的影响。结果表明:一氧化氮合酶抑制剂N-Arg组(100、200μmol/L)NSE免疫反应阳性神经元数目、面积(AF值)及活性(OD值)明显大于空白对照组(P<0.01)。而一氧化氮合酶底物L-Arg组(1mmol/L)神经元面积积分和活性则小于对照组(P<0.01)。L-Arg的细胞毒性作用可为N-Arg逆转。 相似文献
158.
Petal-like apatite formed on the surface of tricalcium phosphate ceramic after soaking in distilled water 总被引:7,自引:0,他引:7
In the present study six types of tricalcium phosphate ceramic were prepared and soaked in distilled water for different periods to investigate whether a surface apatite layer was formed on TCP ceramics or not. X-ray diffractometry (XRD) and Fourier-transformed infrared (FTIR) spectrometer were used to examine the changes in crystalline phases and functional groups of TCP ceramics for different soaking periods. Calcium and phosphate ions released from TCP ceramics during soaking were recorded by atomic absorption analysis and ion-coupled plasma. Results revealed that alphaTCP, alphaTCP/betaTCP mixture (alphabetaTCP) and betaTCP ceramic were gradually dissolved. There was no apatite layer formed on their surface after being immersed in distilled water for different durations of time. Mg-TCP ceramic, tricalcium phosphate doped with Mg ions, exhibited a lower dissolution rate than the other types of TCP ceramics. Apatite crystals were also not formed on the surface of Mg-TCP ceramic when immersed in distilled water. Tribasic calcium phosphate, prepared from wet precipitation method, was converted to betaTCP/HAP (HbetaTCP) or alphaTCP/betaTCP/HAP (HalphabetaTCP) crystalline composition at different sintering temperatures (1,150 degrees C and 1,300 degrees C). The surface apatite layer did not appear on HbetaTCP ceramic after soaking. We observed that petal-like apatite was formed on the HalphabetaTCP ceramic surface after being immersed for 2 weeks. alphaTCP phase of HalphabetaTCP ceramic was not directly converted to apatite during soaking. The surface apatite layer formed on the HalphabetaTCP ceramic surface was due to the precipitation of the calcium and phosphate ions released from alphaTCP dissolution. HAP, which existed in the structure of HalphabetaTCP ceramic, plays a role as apatite-precipitating seed to uptake calcium and phosphate ions. TCP ceramics which lacked alphaTCP and HAP content neither converted to apatite nor formed surface apatite on their surfaces during immersion. 相似文献
159.
胎盘部位过度反应及胎盘部位结节的临床病理分析 总被引:6,自引:1,他引:6
目的探讨胎盘部位过度反应及胎盘部位结节的临床病理学特征以及免疫组织化学染色在鉴别诊断中的意义。方法对15例胎盘部位过度反应及4例胎盘部位结节的临床及病理表现进行回顾性研究,并应用人绒毛膜促性腺激素(hCG)、人胎盘催乳素(hPL)、细胞角蛋白(CK)18、胎盘碱性磷酸酶(PLAP)、α-抑制素(inhibin),进行免疫组织化学染色。结果15例胎盘部位过度反应患者的年龄为25~40岁(平均31.5岁),4例胎盘部位结节患者年龄为26~39岁(平均34.3岁)。15例胎盘部位过度反应的组织学特征为:在子宫内膜、子宫肌层及螺旋动脉中有索条状及片状种植部位中间滋养细胞浸润,子宫内膜及肌层的结构没有破坏。4例胎盘部位结节在子宫内膜组织及变性坏死的绒毛间有多个以致密的嗜酸性玻璃样物质为背景的结节性病变,结节内为绒毛膜型中间滋养细胞。15例胎盘部位过度反应对hPL及CK18均呈阳性反应;4例胎盘部位结节均对CK18、α-抑制素及PLAP均呈阳性反应。所有15例胎盘部位过度反应Ki-67增生指数均≤5%。4例胎盘部位结节Ki-67增生指数均为0。结论胎盘部位过度反应及胎盘部位结节的临床及病理形态学特征不同于滋养细胞肿瘤。免疫组织化学染色对鉴别诊断有帮助。 相似文献
160.
Universally conserved and yeast-specific U1 snRNA sequences are important but not essential for U1 snRNP function 总被引:17,自引:1,他引:16
To study the contribution of the large, 568-nucleotide yeast (Saccharomyces cerevisiae) U1 snRNA to pre-mRNA splicing, we generated mutations in two regions of the molecule and introduced each mutant gene back into yeast as the sole copy of the U1 snRNA gene. We mutagenized the "A loop," a subregion highly conserved in primary sequence in all U1 snRNA molecules analyzed to date. We also mutagenized a portion of the yeast core subdomain, a region conserved in primary and secondary structure among several yeast species but absent from the much smaller metazoan U1 molecule. Surprisingly, mutations in these two regions had little or no effect on growth rate, yet several of them affected an inefficiently spliced reporter gene construct. In addition, combinations of mutants in both regions gave rise to reduced growth rates. Using the latter assay, we confirmed some of the proposed secondary structure of the yeast core domain. The experiments indicate that both regions contribute to U1 snRNP activity but that mutations in a single region do not have a substantial effect on growth rate because U1 snRNP activity is not rate-limiting for growth. 相似文献